Health Care/Hospital APAC News & Press Release Distribution

Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership

SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Standigm Inc.("Standigm"), an AI-based drug discovery company and SK Chemicals Co., Ltd.("SK Chemicals"), a life science and green chemicals company, announced that they had successfully found a new arthritis indication for an FDA-approved drug an...

2021-01-11 07:00 1536

Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients

SUZHOU, China, Jan. 10, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted by Dr.Andy Goren and Dr. Flávio Adsuara C...

2021-01-10 16:55 2862

Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients

NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis

MILAN and HONG KONG, Jan. 8, 2021 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical company headquartered inItaly, and Zhaoke (Hong Kong) Ophthalmology Pharmaceuticals Limited, having a fully integrated ophthalmic platform with strong foundation in eyecare, announce today their agr...

2021-01-08 20:55 4838

Atsushi Sugita Succeeds Koichi Takagi as President & CEO of Maruho

OSAKA, Japan, Jan. 8, 2021 /PRNewswire/ -- Maruho Co., Ltd. (hereinafter "Maruho"), based inOsaka, Japan, announced that its Board of Directors has named Atsushi Sugita Representative Director, President & CEO, effective December 18, 2020. Koichi Takagi has served as President & CEO since 1999 and...

2021-01-08 14:00 3325

EcondLife, A Microchip Programmed Ultrasonic Anti-Virus Humidifier providing Long-term 24-hour Preventive Solution to contain Coronavirus is now available

KUALA LUMPUR, Malaysia, Jan. 8, 2021 /PRNewswire/ -- Eco Awareness launches EcondLife, the world's first smart microchip anti-virus air sanitizing purifier to safeguard people from viruses, including coronavirus[1].

2021-01-08 13:30 3180

EcondLife, A Microchip Programmed Ultrasonic Anti-Virus Humidifier providing Long-term 24-hour Preventive Solution to contain Coronavirus is now available

deCODE genetics: Monozygous but not identical

By sequencing the germline genomes of twins and comparing them to those of close relatives, scientists at deCODE genetics found mutations that are present in just one of themonozygotic twins and traced them back to the first days after conception. REYKJAVIK, Iceland, Jan. 8, 2021 /PRNewswire/ --...

2021-01-08 00:00 2638

deCODE genetics: Monozygous but not identical

First patient in treatment in RhoVac's clinical phase IIb study in United Kingdom

STOCKHOLM, Jan. 7, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on January 7th, 2021, that the first patient in United Kingdom is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac"). The first patient in United Kingdom is enroll...

2021-01-07 22:40 1822

Inteleos and APA Partner to Offer Free Mental Health Resources to All Healthcare Professionals

Participation includes complimentary AMA PRA Category 1 CME Credit™ ROCKVILLE, Maryland. and WASHINGTON, Jan. 7, 2021 /PRNewswire/ -- Inteleos, a non-profit global healthcare certification organization, and theAmerican Psychological Association (APA), the leading scientific and professional or...

2021-01-07 22:02 1820

Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics

MONTREAL, Jan. 7, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners, announced today the acquisition of Clinical Logistics Inc. ("CLI"), a Virtual Central Specimen Management CRO based inHalifax, Canada. The...

2021-01-07 21:20 2013

Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics

Medical Waste Management Inherits a Multi-billion Dollar Opportunity from the Ongoing Pandemic

Asia-Pacific presents immense growth opportunities for medical waste management market participants as regulations mature and are thoroughly enforced, says Frost & Sullivan SANTA CLARA, Calif., Jan. 7, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Growth Opportunities in the Medical Wa...

2021-01-07 21:10 1932

Medical Waste Management Inherits a Multi-billion Dollar Opportunity from the Ongoing Pandemic

Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies

CAMBRIDGE, Mass. and SUZHOU, China, Jan. 7, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the first closing of an oversubscribed$53.5 million Series B+ fina...

2021-01-07 20:31 2387

IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain

- Ocular Pain, a $10+ billion global market, with significant unmet medical need - License agreement aims to accelerate global development of DENKIs, leveraging expertise and resources of both companies IRVINE, California, PARIS, HONG KONG, Jan. 7, 2021 /PRNewswire/ -- IACTA Pharmaceuticals, Inc...

2021-01-07 20:00 2090

Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

- Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain - AmpTec's differentiated polymerase chain reaction (PCR)-based technology has shown to have advantages over other technologies for mRNA manufacturing - Diagnostics business focused on produ...

2021-01-07 17:00 3748

Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange

SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board (the STAR Board) of Shanghai Stock Exchange. The issue price isCNY 74.46 per share. The stock opened at CNY 221.73 ...

2021-01-07 16:13 3151

GEN inCode Appoints New Chairman

OXFORD, England, Jan. 7, 2021 /PRNewswire/ -- GEN inCode UK Limitedthe privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the appointment of Bill Rhodes as non-executive Chairman of the Company, effective 1 Ja...

2021-01-07 15:00 5310

New Thai health drink 'QminC' surges during COVID-19 pandemic

BANGKOK, Jan. 7, 2021 /PRNewswire/ -- Four months after its launch in Thailand , an innovative health drink fortified with curcumin extracted from the turmeric plant's rootstalks, has found its way on to the shelves of more than 15,000 modern trade retail outlets and almost 500,000 mom and pop s...

2021-01-07 11:31 6354

New Thai health drink 'QminC' surges during COVID-19 pandemic

CGTN: What drives China's success in 2020

BEIJING, Jan. 6, 2021 /PRNewswire/ -- Facing unprecedented challenges brought by COVID-19 and the complex changes in external environment, the Communist Party ofChina (CPC) Central Committee with Comrade Xi Jinping at the core has ledChina to achieve substantial progress in 2020. &amp;nb...

2021-01-06 23:16 3247

CGTN: What drives China's success in 2020

Everest Medicines Announces CTA Approval by China NMPA for Phase 3 Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer

SHANGHAI, Jan. 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced th...

2021-01-06 21:54 5701

Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer

SHANGHAI, Jan. 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, announced today th...

2021-01-06 21:52 5912

INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18

- DNA immunotherapy candidate VGX-3100 demonstrated clinically significant reduction of HPV-16/18-associated precancerous vulvar lesions in 63% of treated participants six months after treatment - Phase 2 results indicate that VGX-3100 can be a safe, tolerable and efficacious adjunct to current ...

2021-01-06 21:00 3357